AMIRIDINE (NIK-247) AND CEREBROCRAST IN THE ALLEVIATION OF CHOLINERGIC LESION-INDUCED LEARNING DEFICIT IN MALE-RATS

Citation
Pt. Mannisto et al., AMIRIDINE (NIK-247) AND CEREBROCRAST IN THE ALLEVIATION OF CHOLINERGIC LESION-INDUCED LEARNING DEFICIT IN MALE-RATS, Drug development research, 30(4), 1993, pp. 219-228
Citations number
54
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
02724391
Volume
30
Issue
4
Year of publication
1993
Pages
219 - 228
Database
ISI
SICI code
0272-4391(1993)30:4<219:A(ACIT>2.0.ZU;2-V
Abstract
Learning of the male rats was impaired by injecting ethylcholine aziri dinium (AF64A) bilaterally into the basal magnocellular nuclei of Meyn ert. The performance of the rats in a passive avoidance test and in a one-way active avoidance test was significantly improved by giving a n ovel acetylcholinesterase inhibitor, amiridine (NIK-247; o-2,3,5,6,7,8 -hexahydro-1H-cyclopenta(b)-quinoline monohydrate hydrochloride) after each learning session but not when the drug was given before the sess ions. Cerebrocrast, an antagonist of L-type calcium channels, was not effective in either case. Rather it worsened the learning results when given after the sessions of the active avoidance test. The conclusion s in the passive avoidance test were hampered by the observed inconsis tent effects of cholinotoxin. (C) 1993 Wiley-Liss, Inc.